Healthcare provider profile · identity verified

Pravinchandra C Patel, MD

Internal Medicine · QUINCY, IL · NPI 1548233448

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	404	91
Sertraline Hcl	Sertraline Hcl	291	39
Donepezil Hcl	Donepezil Hcl	278	33
Amlodipine Besylate	Amlodipine Besylate	263	61
Potassium Chloride	Potassium Chloride	263	57
Gabapentin	Gabapentin	259	45
Memantine Hcl	Memantine Hcl	242	30
Levothyroxine Sodium	Levothyroxine Sodium	238	51
Eliquis	Apixaban	233	27
Furosemide	Furosemide	224	45
Lisinopril	Lisinopril	223	56
Pantoprazole Sodium	Pantoprazole Sodium	187	36
Metoprolol Succinate	Metoprolol Succinate	172	36
Omeprazole	Omeprazole	161	45
Carvedilol	Carvedilol	157	34
Metformin Hcl	Metformin Hcl	143	24
Allopurinol	Allopurinol	135	30
Mirtazapine	Mirtazapine	134	25
Tamsulosin Hcl	Tamsulosin Hcl	121	26
Losartan Potassium	Losartan Potassium	117	24
Metoprolol Tartrate	Metoprolol Tartrate	116	24
Rosuvastatin Calcium	Rosuvastatin Calcium	107	18
Spironolactone	Spironolactone	90	23
Simvastatin	Simvastatin	86	24
Pravastatin Sodium	Pravastatin Sodium	83	15
Famotidine	Famotidine	79	19
Albuterol Sulfate Hfa	Albuterol Sulfate	77	18
Clopidogrel	Clopidogrel Bisulfate	71	17
Hydrochlorothiazide	Hydrochlorothiazide	71	21
Carbidopa-Levodopa	Carbidopa/Levodopa	68	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	66	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	61	13
Tramadol Hcl	Tramadol Hcl	59	16
Montelukast Sodium	Montelukast Sodium	57	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	57	suppressed
Finasteride	Finasteride	54	suppressed
Cephalexin	Cephalexin	52	23
Duloxetine Hcl	Duloxetine Hcl	52	suppressed
Irbesartan	Irbesartan	50	13
Risperidone	Risperidone	47	suppressed
Levetiracetam	Levetiracetam	45	suppressed
Buspirone Hcl	Buspirone Hcl	42	suppressed
Novofine Autocover	Pen Needle, Diabetic, Safety	40	suppressed
Atenolol	Atenolol	39	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	37	suppressed
Glipizide Er	Glipizide	37	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	37	suppressed
Primidone	Primidone	37	suppressed
Nystatin	Nystatin	36	15
Xarelto	Rivaroxaban	35	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	34	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	33	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	33	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	32	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	32	suppressed
Divalproex Sodium	Divalproex Sodium	31	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	suppressed
Glipizide	Glipizide	31	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	30	suppressed
Ropinirole Hcl	Ropinirole Hcl	30	suppressed
Citalopram Hbr	Citalopram Hydrobromide	29	suppressed
Fentanyl	Fentanyl	28	suppressed
Jardiance	Empagliflozin	28	suppressed
Valsartan	Valsartan	28	suppressed
Methenamine Hippurate	Methenamine Hippurate	27	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	26	suppressed
Enalapril Maleate	Enalapril Maleate	26	suppressed
Fenofibrate	Fenofibrate	26	suppressed
Tizanidine Hcl	Tizanidine Hcl	26	suppressed
Unifine Safecontrol Pen Needle	Pen Needle,dual Safety,diabetc	26	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	25	suppressed
Benazepril Hcl	Benazepril Hcl	24	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Latanoprost	Latanoprost	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Dapagliflozin	Dapagliflozin Propanediol	23	suppressed
Lorazepam	Lorazepam	22	suppressed
Nebivolol Hcl	Nebivolol Hcl	22	suppressed
Digoxin	Digoxin	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	15
Insulin Aspart Flexpen	Insulin Aspart	20	suppressed
Alendronate Sodium	Alendronate Sodium	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	17
Arexvy	Rsvpref3 Antigen/As01e/Pf	18	18
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Alprazolam	Alprazolam	17	suppressed
Colchicine	Colchicine	17	suppressed
Cyclosporine	Cyclosporine	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Fluticasone Propionate	Fluticasone Propionate	17	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	16	suppressed
Cefuroxime	Cefuroxime Axetil	16	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Torsemide	Torsemide	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	16	suppressed
Scopolamine	Scopolamine	15	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Bumetanide	Bumetanide	14	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	14	suppressed
Letrozole	Letrozole	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Topiramate	Topiramate	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Diltiazem Hcl	Diltiazem Hcl	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Metformin Hcl Er	Metformin Hcl	13	suppressed
Nystop	Nystatin	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Calcitriol	Calcitriol	12	suppressed
Erythromycin	Erythromycin Base	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Lumigan	Bimatoprost	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Nyamyc	Nystatin	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Trazodone Hcl	Trazodone Hcl	12	suppressed
Zonisamide	Zonisamide	12	suppressed
Celecoxib	Celecoxib	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Linzess	Linaclotide	11	suppressed
Lurasidone Hcl	Lurasidone Hcl	11	suppressed
Prednisone	Prednisone	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Prevalite	Cholestyramine	11	suppressed
Tamoxifen Citrate	Tamoxifen Citrate	11	suppressed
Veltassa	Patiromer Calcium Sorbitex	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error